Erratum: Elevated serum levels of S100 and survival in metastatic malignant melanoma

被引：0
|
作者：
机构：
来源：
British Journal of Cancer | 1998年 / 77卷 / 4期
关键词：
D O I：
10.1038/bjc.1998.113
中图分类号：
学科分类号：
摘要：
In the article entitled 'Elevated serum levels of S100 and survival in metastatic malignant melanoma,' which appeared in Br J Cancer 75: 1373-1376, the legend to Figure 1 should be corrected as follows: '...dashed line, low serum levels of S 100 (< 3 ig 1-'); solid line, elevated serum levels of S100 (2 3 gg 1-'.
引用
收藏
页码：681 / 681
相关论文
共 50 条
  • [31] Are responses to therapy of metastasized malignant melanoma reflected by decreasing serum values of S100β or melanoma inhibitory activity (MIA)?
    Deichmann, M
    Benner, A
    Kuner, N
    Wacker, J
    Waldmann, V
    Näher, H
    MELANOMA RESEARCH, 2001, 11 (03) : 291 - 296
  • [32] S100 as Serum Tumor Marker in Advanced Uveal Melanoma
    Salzmann, Martin
    Enk, Alexander H.
    Hassel, Jessica C.
    BIOMOLECULES, 2023, 13 (03)
  • [33] Elevated MIA serum levels are predictors of poor prognosis after surgical resection of metastatic malignant melanoma
    Guba, M
    Steinbauer, M
    Ruhland, V
    Schütz, A
    Geissler, EK
    Anthuber, M
    Vogt, T
    Bosserhoff, A
    Jauch, KW
    ONCOLOGY REPORTS, 2002, 9 (05) : 981 - 984
  • [34] Clinical utility of serum S100 in the therapy monitoring of patients with high risk malignant melanoma.
    Molina, R.
    Auge, J. M.
    Domingo, J.
    Puig, S.
    Filella, X.
    Malvehy, J.
    Castel, T.
    TUMOR BIOLOGY, 2006, 27
  • [35] S100 proteins as cancer biomarkers with focus on S100B in malignant melanoma
    Hatpio, R
    Einarsson, R
    CLINICAL BIOCHEMISTRY, 2004, 37 (07) : 512 - 518
  • [36] Comparison of two prognostic markers for malignant melanoma:: MIA and S100 β
    Juergensen, A
    Holzapfel, U
    Hein, R
    Stolz, W
    Buettner, R
    Bosserhoff, AK
    TUMOR BIOLOGY, 2001, 22 (01) : 54 - 58
  • [37] Evaluation of the Elecsys S100 immumoassay in patients with malignant melanoma.
    Alber, B
    Hein, R
    Luppa, P
    CLINICAL CHEMISTRY, 2004, 50 (06) : A78 - A78
  • [38] Decreases in serum levels of S100 may predict response to therapy in melanoma patients treated with a polyvalent melanoma vaccine
    Bar, A
    Amin, P
    Reynolds, S
    Shapiro, R
    Roses, D
    Harris, M
    Bystryn, J
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2001, 117 (02) : 540 - 540
  • [39] Elevated pretreatment serum levels of soluble vascular cell adhesion molecule 1 and lactate dehydrogenase as predictors of survival in cutaneous metastatic malignant melanoma
    Franzke, A
    Probst-Kepper, M
    Buer, J
    Duensing, S
    Hoffmann, R
    Wittke, F
    Volkenandt, M
    Ganser, A
    Atzpodien, J
    BRITISH JOURNAL OF CANCER, 1998, 78 (01) : 40 - 45
  • [40] Elevated pretreatment serum levels of soluble vascular cell adhesion molecule 1 and lactate dehydrogenase as predictors of survival in cutaneous metastatic malignant melanoma
    A Franzke
    M Probst-Kepper
    J Buer
    S Duensing
    R Hoffmann
    F Wittke
    M Volkenandt
    A Ganser
    J Atzpodien
    British Journal of Cancer, 1998, 78 : 40 - 45
12345